New insights into MAIT cells in autoimmune diseases

Biomed Pharmacother. 2023 Mar:159:114250. doi: 10.1016/j.biopha.2023.114250. Epub 2023 Jan 16.

Abstract

Mucosal-associated invariant T (MAIT) cells are resident T cells that express semi-invariant TCR chains and are restricted by monomorphic major histocompatibility complex (MHC) class I-related molecules (MR1). MAIT cells can be activated by microbial-specific metabolites (MR1-dependent mode) or cytokines (MR1-independent mode). Activated MAIT cells produce chemokines, cytotoxic molecules (granzyme B and perforin), and proinflammatory cytokines (IFN-γ, TNF-α, and IL-17), to clear pathogens and target infected cells involved in the pro-inflammatory, migratory, and cytolytic properties of MAIT cells. MAIT cells produce pro-inflammatory cytokines in the target organs of autoimmune diseases and contribute to the development and progression of autoimmune diseases. This article reviews the biological characteristics, activation mechanism, dynamic migration, and dual functions of MAIT cells, and focuses on the mechanism and potential application of MAIT cells in the early diagnosis, disease activity monitoring, and therapeutic targets of autoimmune diseases, to lay a foundation for future research.

Keywords: Activation mechanisms; Autoimmune diseases; Dual functions; Mucosal-associated invariant T cell; Proinflammation.

Publication types

  • Review

MeSH terms

  • Autoimmune Diseases*
  • Cytokines
  • Histocompatibility Antigens Class I
  • Humans
  • Minor Histocompatibility Antigens
  • Mucosal-Associated Invariant T Cells* / metabolism

Substances

  • Cytokines
  • Histocompatibility Antigens Class I
  • Minor Histocompatibility Antigens